Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial.
| Image |  |
|---|---|
| Description | scientific article published on 17 February 2014 |
| Author/s |
author: Nicholas J. Vogelzang Emilio Esteban Cora Sternberg Georg A. Bjarnason Robert Motzer Sun Young Rha Ugo De Giorgi Camillo Porta Cezary Szczylik |
| Publication date | February 17, 2014 |
| Language | |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |